Charting individualized pathways: IGF-1 and vitamin D in guiding personalized medicine for residual risk after AMI

Progress in Cardiovascular Diseases · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles